Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OS actually shrank today
Partnership with some Italian co called GADA. Just PRed in Italy. Don’t know how it was found but checks out. Saw it on another forum.
Ya most longs have averages higher than that.
Well.... that’s cool... except the price target
PM price was over $4. The rest is history
Warrants exercise trigger was $3.65. They were free to dump. Sure some shorts rode that, but warrants acct for the vol and steady decline.
$5K for a stent is outrageous. $2-3K is realistic. We’re talking the product unit, not the procedure. And w future FDA approval does not mean there’s gonna be millions of people scheduling surgery.
BUT it does make us prime for a BO now. It’s been discussed extensively on other forums. And today’s fast track designation makes us a target for deep pockets. Especially if the technology could be repurposed for other conditions (I don’t know what they would be)
It’s dilution today more than shorts. Normally you’d be right, but not this time.
US market >10M people w angina. Something like 200-300K new cases annually
Today’s high going >$3.65 triggered note holders to freely dilute. So today’s drop after PM is dilution. BUT it should hopefully signal an end to dilution. And warrants being exercised...
We didn’t get FDA approval, we got “breakthrough technology designation”. This gives us “fast track” approval designation. So basically we’re on our way to FDA approval in <6 mos. AND THAT makes us now a very prime candidate for a BO. More than any other news so far.
Sooooooo
We’re compliant....
There’s “unofficial” news. The guy that received the reducer in June 17 had a 10 week follow up with great results to quality of life. From constant pain to walking miles per day with little to no issues.
First recipient in the US shows great results on 30 min minimally invasive procedure. VERY POSITIVE
Yes, clearly...
WHAT IF...
ANNOUNCING RS IN 1 MO FORCES ALL WARRANTS, ENDS DILUTION, PRE-BO, so NO SURPRISES FOR BO- CO...?
MAYBE...
Think about it
That’s not gonna create a 100% run. 20-30% MAYBE...
Interesting factoid: Marko sold off all of his remaining shares on 8/29, cleared 9/5. Frost story 9/7...
It doesn’t.
Computers? I use my phone...
Looks like judge bouroughs (spelling...) is rendering a court hearing decision on sept 13 (next thurs). Court docket was posted on stock tw*ts.
On stock tw*ts someone posted in 2016 BSX took out a $400M loan and 1 Mo later bought a co for $450M. (Sorry I forget the details, but it checked out. My memory just sucks). Less than 2 weeks ago BSX took out a $1B loan.
I saw it from a copy/pasted link on stock twits. You could probably find it google “$15,000 nasdaq” or something
All it could say is that there was a hearing. Judgement takes up to 30 days.
Of course it would. The rule of thumb is if it isn’t written down, it didn’t happen.
The panel has up to 30 days to make a ruling/judgement
Boston Sci took out a $1B+ loan last week with 4 banks including BoA and Wells Fargo.
There’s a NASDAQ rule that says any financial institution can not hold more than $15K worth of assets during merger/acq/business deals where they could benefit during involvement (conf of interests)
BoA HELD 17k shares but recently SOLD ALL BUT 1000 shares of NVCN.
FYI: 17K x $1.00 = $17K
17K x $0.75 = $12,750
Interesting...
check out stock tw*ts. Some of the DD posted are outstanding
Good point...
Food for thought. They could have RSed at any time but have not. Are buying time. WHY...?
That’s what I think too. High level research hospital with major visibility. That HAS to be enormous for company development.
Just look under trades. Several million AH mostly on the ask.
Big buys AH?! Strange buying or a big short coming. Not sure which.
I bet there are a lot of people that feel that way
That was a long post for arguing semantics. 100:1, 1:100, I think anyone who read it understood what he meant.
It only restates the F10
And it’s what they did with the BSX deal. Plus they hired a new legal firm that specializes in acquisitions and mergers
But it’s in line with many of the discussion points of past PRs and CCs
It’s a done deal. There is a merger in the works. Read:
Https://www.sec.gov/files/formf-10.pdf
Whose read the ENTIRE F-10 SEC General Eligibility Requirements for Use? It’s all about mergers, exchanges, and business combination!!
At our PPS, we could do more than 500%